Vildagliptin is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. Vildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. Vildagliptin (LAF237) is an orally active antihyperglycemic agent that selectively inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme. Vildagliptin is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adults. It works by increasing the activity of hormones that help maintain your blood sugar levels before or after a meal. Vildagliptin may result in low blood sugar levels, and you may feel hungry, irritable, confused, anxious, or shaky. It is always recommended to eat or drink a fast-acting source of sugar (fruit juice, candy, raisins, etc.) to quickly treat these symptoms ... Vildagliptin is an antidiabetic injection that is used to treat diabetes. For more information about diabetes treatments and vildagliptin visit Patient

Available

Product reviews

Rating 4.5 out of 5. 8,008 reviews.

Characteristics assessment

Cost-benefit

Rating 4.5 out of 10 5

Comfortable

Rating 4.3 out of 5

It's light

Rating 4.3 out of 5

Quality of materials

Rating 4.1 of 5

Easy to assemble

Assessment 4 of 5